Susquehanna International Group, LLP Protagonist Therapeutics, Inc Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	SELL	$24.66 - $34.8 $438,948 - $619,440	-17,800 Reduced 71.77%	7,000 $242,000
Q1 2024 May 07, 2024	SELL	$21.79 - $32.15 $3.56 Million - $5.26 Million	-163,600 Reduced 86.84%	24,800 $717,000
Q4 2023 Feb 14, 2024	SELL	$14.05 - $23.44 $115,210 - $192,208	-8,200 Reduced 4.17%	188,400 $4.32 Million
Q3 2023 Nov 14, 2023	SELL	$16.68 - $23.66 $3.3 Million - $4.68 Million	-197,600 Reduced 50.13%	196,600 $3.28 Million
Q2 2023 Aug 11, 2023	SELL	$18.02 - $29.36 $3.73 Million - $6.07 Million	-206,800 Reduced 34.41%	394,200 $10.9 Million
Q1 2023 May 16, 2023	BUY	$10.78 - $25.38 $2.69 Million - $6.32 Million	249,200 Added 70.84%	601,000 $13.8 Million
Q4 2022 Feb 14, 2023	BUY	$7.36 - $11.17 $1.05 Million - $1.59 Million	142,300 Added 67.92%	351,800 $3.84 Million
Q3 2022 Nov 14, 2022	BUY	$7.86 - $11.71 $194,142 - $289,237	24,700 Added 13.37%	209,500 $1.77 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $25.52 $655,874 - $2.37 Million	92,900 Added 101.09%	184,800 $1.46 Million
Q1 2022 May 16, 2022	SELL	$23.34 - $36.08 $3.33 Million - $5.15 Million	-142,700 Reduced 60.83%	91,900 $2.18 Million
Q4 2021 Feb 14, 2022	SELL	$17.63 - $37.1 $3.06 Million - $6.43 Million	-173,400 Reduced 42.5%	234,600 $8.02 Million
Q3 2021 Nov 15, 2021	BUY	$12.95 - $49.69 $5.16 Million - $19.8 Million	398,800 Added 4334.78%	408,000 $7.23 Million
Q2 2021 Aug 11, 2021	SELL	$25.57 - $44.88 $204,560 - $359,040	-8,000 Reduced 46.51%	9,200 $413,000
Q1 2021 May 17, 2021	BUY	$19.02 - $31.15 $127,434 - $208,705	6,700 Added 63.81%	17,200 $445,000
Q4 2020 Feb 16, 2021	BUY	$18.49 - $25.13 $194,144 - $263,865	10,500 New	10,500 $212,000

Others Institutions Holding PTGX

# of Institutions

212

Shares Held

59.1M

Call Options Held

19K

Put Options Held

107K

Farallon Capital Management LLC San Francisco, CA

5.84M
Shares

$278 Million
0.98% of portfolio
Black Rock Inc. New York, NY

5.76M
Shares

$274 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.29M
Shares

$252 Million
3.06% of portfolio
Bvf Inc San Francisco, CA

3.32M
Shares

$158 Million
3.52% of portfolio
Vanguard Group Inc Valley Forge, PA

3.24M
Shares

$154 Million
0.0% of portfolio

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.34B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account